Free Trial
NYSE:AVTR

Avantor (AVTR) Stock Price, News & Analysis

Avantor logo
$15.82 +0.04 (+0.22%)
Closing price 03:59 PM Eastern
Extended Trading
$15.82 -0.01 (-0.06%)
As of 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avantor Stock (NYSE:AVTR)

Key Stats

Today's Range
$15.68
$16.37
50-Day Range
$15.50
$22.60
52-Week Range
$15.37
$28.00
Volume
7.96 million shs
Average Volume
6.69 million shs
Market Capitalization
$10.78 billion
P/E Ratio
15.22
Dividend Yield
N/A
Price Target
$25.50
Consensus Rating
Moderate Buy

Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Remove Ads

Avantor Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

AVTR MarketRank™: 

Avantor scored higher than 98% of companies evaluated by MarketBeat, and ranked 14th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avantor has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 9 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Avantor has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Avantor's stock forecast and price target.
  • Earnings Growth

    Earnings for Avantor are expected to grow by 13.21% in the coming year, from $1.06 to $1.20 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avantor is 15.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.15.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avantor is 15.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.64.

  • Price to Earnings Growth Ratio

    Avantor has a PEG Ratio of 1.55. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Avantor has a P/B Ratio of 1.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Avantor's valuation and earnings.
  • Percentage of Shares Shorted

    4.22% of the float of Avantor has been sold short.
  • Short Interest Ratio / Days to Cover

    Avantor has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Avantor has recently decreased by 13.19%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Avantor does not currently pay a dividend.

  • Dividend Growth

    Avantor does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.22% of the float of Avantor has been sold short.
  • Short Interest Ratio / Days to Cover

    Avantor has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Avantor has recently decreased by 13.19%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Avantor has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Avantor this week, compared to 9 articles on an average week.
  • Search Interest

    10 people have searched for AVTR on MarketBeat in the last 30 days. This is an increase of 900% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Avantor to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avantor insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $151,897.00 in company stock.

  • Percentage Held by Insiders

    Only 1.50% of the stock of Avantor is held by insiders.

  • Percentage Held by Institutions

    95.08% of the stock of Avantor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Avantor's insider trading history.
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

AVTR Stock News Headlines

Alert: DOGE goes live
Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest economic transformation in American history. See, there's one particular part of Elon and Trump's plans that you need to pay special attention to right now.
Avantor price target lowered to $18 from $22 at Citi
See More Headlines

AVTR Stock Analysis - Frequently Asked Questions

Avantor's stock was trading at $21.07 on January 1st, 2025. Since then, AVTR stock has decreased by 24.9% and is now trading at $15.8250.
View the best growth stocks for 2025 here
.

Avantor, Inc. (NYSE:AVTR) issued its quarterly earnings results on Wednesday, February, 12th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.01. Avantor had a trailing twelve-month return on equity of 12.17% and a net margin of 10.49%.

Avantor (AVTR) raised $3 billion in an initial public offering (IPO) on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Top institutional shareholders of Avantor include Dodge & Cox (14.57%), Vanguard Group Inc. (9.40%), T. Rowe Price Investment Management Inc. (6.08%) and Barrow Hanley Mewhinney & Strauss LLC (4.49%). Insiders that own company stock include Michael Stubblefield, Frederic Vanderhaegen, Gerard Brophy, Christophe Couturier, James Bramwell, Steven W Eck and Thomas A Szlosek.
View institutional ownership trends
.

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avantor investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Humana (HUM), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
2/12/2025
Today
3/13/2025
Next Earnings (Estimated)
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:AVTR
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.50
High Stock Price Target
$31.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+59.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

Trailing P/E Ratio
15.35
Forward P/E Ratio
15.04
P/E Growth
1.55
Net Income
$711.50 million
Pretax Margin
12.59%

Debt

Sales & Book Value

Annual Sales
$6.78 billion
Cash Flow
$1.48 per share
Price / Cash Flow
10.76
Book Value
$8.75 per share
Price / Book
1.82

Miscellaneous

Free Float
672,051,000
Market Cap
$10.86 billion
Optionable
Optionable
Beta
1.30
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:AVTR) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners